Lipoprotein[a] and cancer: Anti-neoplastic effect besides its cardiovascular potency
Authors:
- Giuseppe LippiGiuseppe Lippi
- Massimo FranchiniMFMassimo Franchini
- Gian Luca SalvagnoGian Luca Salvagno
- Gian Cesare GuidiGGGian Cesare Guidi
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 33 (5) , 427-436
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in miceHepatology, 2006
- Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) KringlesCancer Research, 2004
- Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis modelBritish Journal of Surgery, 2002
- The Tumor-Suppressing Activity of Angiostatin Protein Resides within Kringles 1 to 3Biochemical and Biophysical Research Communications, 1999
- Apolipoprotein(a), a Link between Atherosclerosis and Tumor AngiogenesisBiochemical and Biophysical Research Communications, 1999
- Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapyArchives of internal medicine (1960), 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Kringles: modules specialized for protein bindingFEBS Letters, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971